Clinical Trials Logo

Clinical Trial Summary

This is a prospective, comparative, open-label, single-center, randomized, investigator-sponsored clinical study and seeks to investigate clinical outcomes with standard of care and high dose DEXTENZA treatment compared to standard of care topical dexamethasone in patients undergoing trabeculectomy, trabeculectomy Ex-PRESS, Xen Gel stent, and Ahmed Valve surgery. Patients will be followed through 6 months. After screening a given patient for inclusion and exclusion criteria, and gaining informed consent, eyes of n=30 patients will be randomized to one of the following two groups (n=15per group) and followed from Baseline through Month 6.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05116345
Study type Interventional
Source University of Tennessee Health Science Center
Contact Brian Jerkins, MD
Phone 901-338-1022
Email [email protected]
Status Not yet recruiting
Phase Phase 4
Start date November 2021
Completion date November 2023